Cargando…
Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”
Autores principales: | Zhou, Shaolan, Zhang, Jing, Luan, Pengfei, Ma, Zhanbing, Dang, Jie, Zhu, Hong, Ma, Qian, Wang, Yanfeng, Huo, Zhenghao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449717/ https://www.ncbi.nlm.nih.gov/pubmed/34545332 http://dx.doi.org/10.1155/2021/9818203 |
Ejemplares similares
-
miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus
por: Zhou, Shaolan, et al.
Publicado: (2021) -
Profile of atacicept and its potential in the treatment of systemic lupus erythematosus [Corrigendum]
Publicado: (2015) -
Identification of hub genes, pathways, and related transcription factors in systemic lupus erythematosus: A preliminary bioinformatics analysis
por: Wang, Yanfeng, et al.
Publicado: (2021) -
Identification and Clinical Correlation Analysis of IFI44 in Systemic Lupus Erythematosus Combined with Bioinformatics and Immune Infiltration Analysis
por: Wang, Yuan, et al.
Publicado: (2023) -
Corrigendum: MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1
por: Li, Yi, et al.
Publicado: (2020)